Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin L Roggen

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Basic & Clinical Pharmacology & Toxicology|January 30, 2014
In vitro approaches for detection of chemical sensitizationErwin L Roggen
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 16, 2012
Application of the acquired knowledge and implementation of the Sens-it-iv toolbox for identification and classification of skin and respiratory sensitizersErwin L Roggen
Frontiers in Pharmacology|June 30, 2011
In vitro Toxicity Testing in the Twenty-First CenturyErwin L Roggen
Journal of Immunotoxicology|October 30, 2008
Recent developments with B-cell epitope identification for predictive studiesErwin L Roggen
Drug Discovery Today. Technologies|July 2, 2014
B-cell epitope engineering: A matter of recognizing protein features and motivesErwin L Roggen
Alternatives to Laboratory Animals : ATLA|October 8, 2009
Immunotoxicology: opportunities for non-animal test developmentEmanuela Corsini, Erwin L Roggen
Journal of Alzheimer'S Disease Reports|July 27, 2022
Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429)Maria Tsamou, Erwin L Roggen
Brain Research|February 2, 2024
Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD)Maria Tsamou, Erwin L Roggen
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 16, 2013
Sens-it-iv: a European Union project to develop novel tools for the identification of skin and respiratory sensitizersErwin L Roggen, Bas J Blaauboer
Journal of Alzheimer'S Disease : JAD|April 12, 2021
A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental NeurotoxicantsMaria Tsamou, Francesca Pistollato, Erwin L Roggen
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Basic & Clinical Pharmacology & Toxicology|January 30, 2014
In vitro approaches for detection of chemical sensitizationErwin L Roggen
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 16, 2012
Application of the acquired knowledge and implementation of the Sens-it-iv toolbox for identification and classification of skin and respiratory sensitizersErwin L Roggen
Frontiers in Pharmacology|June 30, 2011
In vitro Toxicity Testing in the Twenty-First CenturyErwin L Roggen
Journal of Immunotoxicology|October 30, 2008
Recent developments with B-cell epitope identification for predictive studiesErwin L Roggen
Drug Discovery Today. Technologies|July 2, 2014
B-cell epitope engineering: A matter of recognizing protein features and motivesErwin L Roggen
Alternatives to Laboratory Animals : ATLA|October 8, 2009
Immunotoxicology: opportunities for non-animal test developmentEmanuela Corsini, Erwin L Roggen
Journal of Alzheimer'S Disease Reports|July 27, 2022
Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429)Maria Tsamou, Erwin L Roggen
Brain Research|February 2, 2024
Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD)Maria Tsamou, Erwin L Roggen
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 16, 2013
Sens-it-iv: a European Union project to develop novel tools for the identification of skin and respiratory sensitizersErwin L Roggen, Bas J Blaauboer
Journal of Alzheimer'S Disease : JAD|April 12, 2021
A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental NeurotoxicantsMaria Tsamou, Francesca Pistollato, Erwin L Roggen
Pageof 4